Aurobindo’s 119% Rise Among World’s Best on U.S. Growth

Updated on

Aurobindo Pharma Ltd.’s stock surge in the past year is among the highest for the world’s drugmakers, as the Indian company weathers a U.S. clampdown on foreign manufacturers of generics and wins more product approvals.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.